- Home
- SAR vs BNTC Comparison
SAR vs BNTC Comparison
Compare SAR & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAR
- BNTC
- Stock Information
- Founded
- SAR 2007
- BNTC 1995
- Country
- SAR United States
- BNTC United States
- Employees
- SAR N/A
- BNTC N/A
- Industry
- SAR Investment Managers
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- SAR Finance
- BNTC Health Care
- Exchange
- SAR Nasdaq
- BNTC Nasdaq
- Market Cap
- SAR 373.4M
- BNTC 366.6M
- IPO Year
- SAR 2007
- BNTC N/A
- Fundamental
- Price
- SAR $24.84
- BNTC $12.89
- Analyst Decision
- SAR Hold
- BNTC Strong Buy
- Analyst Count
- SAR 4
- BNTC 6
- Target Price
- SAR $24.75
- BNTC $23.83
- AVG Volume (30 Days)
- SAR 100.1K
- BNTC 234.8K
- Earning Date
- SAR 07-08-2025
- BNTC 05-14-2025
- Dividend Yield
- SAR 12.07%
- BNTC N/A
- EPS Growth
- SAR 105.87
- BNTC N/A
- EPS
- SAR 2.47
- BNTC N/A
- Revenue
- SAR $142,495,705.00
- BNTC N/A
- Revenue This Year
- SAR N/A
- BNTC N/A
- Revenue Next Year
- SAR $2.28
- BNTC N/A
- P/E Ratio
- SAR $10.06
- BNTC N/A
- Revenue Growth
- SAR N/A
- BNTC N/A
- 52 Week Low
- SAR $21.10
- BNTC $7.05
- 52 Week High
- SAR $26.49
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- SAR 52.87
- BNTC 50.13
- Support Level
- SAR $24.01
- BNTC $12.57
- Resistance Level
- SAR $25.47
- BNTC $13.88
- Average True Range (ATR)
- SAR 0.37
- BNTC 1.18
- MACD
- SAR -0.01
- BNTC 0.02
- Stochastic Oscillator
- SAR 56.85
- BNTC 62.63
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.